Aquestive Long Term Investments from 2010 to 2025
| AQST Stock | USD 3.21 0.09 2.88% |
Long Term Investments | First Reported 2010-12-31 | Previous Quarter 5.4 K | Current Value 4.8 K | Quarterly Volatility 326.34337744 |
Check Aquestive Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aquestive Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 10.3 M, Selling General Administrative of 44.5 M or Total Revenue of 49.6 M, as well as many indicators such as Price To Sales Ratio of 3.99, Dividend Yield of 0.0 or Days Sales Outstanding of 63.82. Aquestive financial statements analysis is a perfect complement when working with Aquestive Therapeutics Valuation or Volatility modules.
Aquestive | Long Term Investments |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aquestive Stock Analysis
When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.